These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Non-alcoholic fatty liver disease as a cause and a consequence of metabolic syndrome. Yki-Järvinen H Lancet Diabetes Endocrinol; 2014 Nov; 2(11):901-10. PubMed ID: 24731669 [TBL] [Abstract][Full Text] [Related]
25. Molecular mechanisms of steatosis in nonalcoholic fatty liver disease. Pettinelli P; Obregón AM; Videla LA Nutr Hosp; 2011; 26(3):441-50. PubMed ID: 21892559 [TBL] [Abstract][Full Text] [Related]
26. Non-Alcoholic Fatty Liver Disease. Engin A Adv Exp Med Biol; 2017; 960():443-467. PubMed ID: 28585211 [TBL] [Abstract][Full Text] [Related]
27. Hepatocellular Carcinoma in the Setting of Non-cirrhotic Nonalcoholic Fatty Liver Disease and the Metabolic Syndrome: US Experience. Perumpail RB; Wong RJ; Ahmed A; Harrison SA Dig Dis Sci; 2015 Oct; 60(10):3142-8. PubMed ID: 26250831 [TBL] [Abstract][Full Text] [Related]
28. Redox balance in the pathogenesis of nonalcoholic fatty liver disease: mechanisms and therapeutic opportunities. Gambino R; Musso G; Cassader M Antioxid Redox Signal; 2011 Sep; 15(5):1325-65. PubMed ID: 20969475 [TBL] [Abstract][Full Text] [Related]
29. Prevalence of nonalcoholic fatty liver disease and its metabolic risk factors in women of different ages and body mass index. Wang Z; Xu M; Hu Z; Shrestha UK Menopause; 2015 Jun; 22(6):667-73. PubMed ID: 25513983 [TBL] [Abstract][Full Text] [Related]
30. Pathology of nonalcoholic fatty liver disease. Yeh MM; Brunt EM Am J Clin Pathol; 2007 Nov; 128(5):837-47. PubMed ID: 17951208 [TBL] [Abstract][Full Text] [Related]
31. Different Serum Free Fatty Acid Profiles in NAFLD Subjects and Healthy Controls after Oral Fat Load. Gambino R; Bugianesi E; Rosso C; Mezzabotta L; Pinach S; Alemanno N; Saba F; Cassader M Int J Mol Sci; 2016 Mar; 17(4):479. PubMed ID: 27043543 [TBL] [Abstract][Full Text] [Related]
33. Prevalence, risk factors, and predictors of nonalcoholic fatty liver disease among schoolchildren: a hospital-based study in Alexandria, Egypt. Alkassabany YM; Farghaly AG; El-Ghitany EM Arab J Gastroenterol; 2014 Jun; 15(2):76-81. PubMed ID: 25097051 [TBL] [Abstract][Full Text] [Related]
34. Current status of liver disease in Korea: nonalcoholic fatty liver disease. Park SH Korean J Hepatol; 2009 Dec; 15 Suppl 6():S34-9. PubMed ID: 20037278 [TBL] [Abstract][Full Text] [Related]
35. Cholelithiasis and markers of nonalcoholic fatty liver disease in patients with metabolic risk factors. Koller T; Kollerova J; Hlavaty T; Huorka M; Payer J Scand J Gastroenterol; 2012 Feb; 47(2):197-203. PubMed ID: 22182015 [TBL] [Abstract][Full Text] [Related]
36. The central role of the non alcoholic fatty liver disease in metabolic syndrome. Hurjui DM; Niţă O; Graur LI; Mihalache L; Popescu DS; Graur M Rev Med Chir Soc Med Nat Iasi; 2012; 116(2):425-31. PubMed ID: 23077931 [TBL] [Abstract][Full Text] [Related]
37. Attenuated lipotoxicity and apoptosis is linked to exogenous and endogenous augmenter of liver regeneration by different pathways. Weiss TS; Lupke M; Ibrahim S; Buechler C; Lorenz J; Ruemmele P; Hofmann U; Melter M; Dayoub R PLoS One; 2017; 12(9):e0184282. PubMed ID: 28877220 [TBL] [Abstract][Full Text] [Related]